Related references
Note: Only part of the references are listed.TCR gene therapy of spontaneous prostate carcinoma requires in vivo T cell activation
Moniek A. de Witte et al.
JOURNAL OF IMMUNOLOGY (2008)
Requirements for effective antitumor responses of TCR transduced T cells
Moniek A. de Witte et al.
JOURNAL OF IMMUNOLOGY (2008)
Human TCR that incorporate CD3ζ induce highly preferred pairing between TCRα and β chains following gene transfer
Zsolt Sebestyen et al.
JOURNAL OF IMMUNOLOGY (2008)
Molecular design of the C alpha beta interface favors specific pairing of introduced TCR alpha beta in human T cells
Ralf-Holger Voss et al.
JOURNAL OF IMMUNOLOGY (2008)
Targeting the Wilms tumor antigen 1 by TCR gene transfer:: TCR variants improve tetramer binding but not the function of gene modified human T cells
Sharyn Thomas et al.
JOURNAL OF IMMUNOLOGY (2007)
Dual T cell receptor expressing CD8+ T cells with tumor- and self-specificity can inhibit tumor growth without causing severe autoimmunity
Monika Weinhold et al.
JOURNAL OF IMMUNOLOGY (2007)
Generation of T cell help through a MHC class I-Restricted TCR
Helmut W. H. G. Kessels et al.
JOURNAL OF IMMUNOLOGY (2006)
Telomere length of transferred lymphocytes correlates with in vivo persistence and tumor regression in melanoma patients receiving cell transfer therapy
JH Zhou et al.
JOURNAL OF IMMUNOLOGY (2005)
Opposing effects of IL-2 in tumor immunotherapy: Promoting CD8 T cell growth and inducing apoptosis
P Shrikant et al.
JOURNAL OF IMMUNOLOGY (2002)
Share Paper
